CLINICAL_TRIALS
trial_result
· 2016-11-18
Clinical Trial Update: Safety And Tolerability Of Escalating Intravenous Doses Of PF-05231023 In Adult Subjects With Type 2 Diabetes [Phase 1]
Summary
This Phase 1 trial evaluates the safety and tolerability of escalating intravenous doses of PF-05231023 in adults with Type 2 diabetes mellitus.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED | Results posted: 2016-11-18